Literature DB >> 21903875

Cardiac and vascular responses to thigh cuffs and respiratory maneuvers on crewmembers of the International Space Station.

Douglas R Hamilton1, Ashot E Sargsyan, Kathleen Garcia, Douglas J Ebert, Peggy A Whitson, Alan H Feiveson, Irina V Alferova, Scott A Dulchavsky, Vladimir P Matveev, Valery V Bogomolov, J Michael Duncan.   

Abstract

BACKGROUND: The transition to microgravity eliminates the hydrostatic gradients in the vascular system. The resulting fluid redistribution commonly manifests as facial edema, engorgement of the external neck veins, nasal congestion, and headache. This experiment examined the responses to modified Valsalva and Mueller maneuvers measured by cardiac and vascular ultrasound (ECHO) in a baseline steady state and under the influence of thigh occlusion cuffs available as a countermeasure device (Braslet cuffs).
METHODS: Nine International Space Station crewmember subjects (expeditions 16-20) were examined in 15 experiment sessions 101 ± 46 days after launch (mean ± SD; 33-185). Twenty-seven cardiac and vascular parameters were obtained with/without respiratory maneuvers before and after tightening of the Braslet cuffs (162 parameter states/session). Quality of cardiac and vascular ultrasound examinations was assured through remote monitoring and guidance by investigators from the NASA Telescience Center in Houston, TX, and the Mission Control Center in Korolyov, Moscow region, Russia.
RESULTS: 14 of 81 conditions (27 parameters measured at baseline, Valsalva, and Mueller maneuver) were significantly different when the Braslet was applied. Seven of 27 parameters were found to respond differently to respiratory maneuvers depending on the presence or absence of thigh compression.
CONCLUSIONS: Acute application of Braslet occlusion cuffs causes lower extremity fluid sequestration and exerts commensurate measurable effects on cardiac performance in microgravity. Ultrasound techniques to measure the hemodynamic effects of thigh cuffs in combination with respiratory maneuvers may serve as an effective tool in determining the volume status of a cardiac or hemodynamically compromised patient at the "microgravity bedside."

Entities:  

Mesh:

Year:  2011        PMID: 21903875     DOI: 10.1152/japplphysiol.00557.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  Lymphedema outcomes in patients with head and neck cancer.

Authors:  Brad G Smith; Katherine A Hutcheson; Leila G Little; Roman J Skoracki; David I Rosenthal; Stephen Y Lai; Jan S Lewin
Journal:  Otolaryngol Head Neck Surg       Date:  2014-11-11       Impact factor: 3.497

Review 2.  Skeletal changes during and after spaceflight.

Authors:  Laurence Vico; Alan Hargens
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

3.  Left ventricular remodeling during and after 60 days of sedentary head-down bed rest.

Authors:  Christian M Westby; David S Martin; Stuart M C Lee; Michael B Stenger; Steven H Platts
Journal:  J Appl Physiol (1985)       Date:  2015-10-22

4.  Effects of short-term exposure to head-down tilt on cerebral hemodynamics: a prospective evaluation of a spaceflight analog using phase-contrast MRI.

Authors:  Karina Marshall-Goebel; Khalid Ambarki; Anders Eklund; Jan Malm; Edwin Mulder; Darius Gerlach; Eric Bershad; Jörn Rittweger
Journal:  J Appl Physiol (1985)       Date:  2016-03-24

5.  Future research directions to identify risks and mitigation strategies for neurostructural, ocular, and behavioral changes induced by human spaceflight: A NASA-ESA expert group consensus report.

Authors:  Rachael D Seidler; Claudia Stern; Mathias Basner; Alexander C Stahn; Floris L Wuyts; Peter Zu Eulenburg
Journal:  Front Neural Circuits       Date:  2022-08-04       Impact factor: 3.342

6.  The accuracy of the new landmark using respiratory jugular venodilation and direct palpation in right internal jugular vein access.

Authors:  Hyungseok Seo; Dong-Min Jang; Jung-Min Yi; Hong-Gi Min; Jai-Hyun Hwang
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.